Omnicell (OMCL) Change in Account Payables (2010 - 2026)
Omnicell's (OMCL) quarterly Change in Account Payables came in at -$8.9 million in Q2 2026, down 191.6% year-over-year from $9.8 million in Q2 2025, and down 155.25% quarter-over-quarter from $16.2 million in Q1 2026.
Analysis
Omnicell (OMCL) Change in Account Payables (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Change in Account Payables for 17 consecutive years, with -$8.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Account Payables fell 191.6% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was -$12.7 million, a 196.85% decrease from a year earlier, with the FY2025 full-year figure at -$9.3 million, down 228.75% from the prior year.
- Change in Account Payables was -$8.9 million for Q2 2026 at Omnicell, down from $16.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $16.2 million in Q1 2026 and troughed at -$20.0 million in Q4 2025.
- A 5-year average of -$1.1 million and a median of $13000.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 7315.0% in 2024 and surged 1637.49% in 2026, its largest moves.
- Over 5 years, Change in Account Payables stood at -$9.8 million in 2022, then surged by 57.47% to -$4.2 million in 2023, then surged by 202.35% to $4.3 million in 2024, then plunged by 568.42% to -$20.0 million in 2025, then soared by 55.26% to -$8.9 million in 2026.
- The last three Change in Account Payables figures came in at -$8.9 million (Q2 2026), $16.2 million (Q1 2026), and -$20.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | - |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | -8.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.94 Mn |
| Mar 31, 2026 | 16.18 Mn |
| Dec 31, 2025 | -19.98 Mn |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 9.76 Mn |
| Mar 31, 2025 | 931,000.00 |
| Dec 31, 2024 | 4.27 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | -1.44 Mn |
| Dec 31, 2023 | -4.17 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | -15.83 Mn |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | -9.80 Mn |
| Sep 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | 312,000.00 |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | 17.43 Mn |